LOGO
LOGO

Corporate News

Timken Q4 Earnings Down; Guides FY26

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

The Timken Co. (TKR), an engineered bearings and industrial motion, on Wednesday reported its net income declined despite higher net sales compared with the previous year.

For the fourth quarter, net income attributable to the company declined to $62.3 million from $71.2 million in the previous year.

Earnings per share were $0.89 versus $1.01 last year.

Adjusted net income attributable to the company decreased to $80.4 million from $81.5 million in the same period last year.

Adjusted earnings per share were $1.14 versus $1.16 last year.

On average, 13 analysts had expected the company to report $1.09 per share. Analysts' estimates typically exclude special items.

Adjusted EBITDA slid to $177.8 million from $178.2 million in the last year.

Operating income declined to $109.4 million from $113 million in the prior year.

Net sales increased to $1.11 billion from $1.07 billion in the previous year.

For the fiscal year 2026, the company expected earnings per share in the range of $4.50 to $5 and adjusted earnings per share in the range of $5.50 to $6.

The company is planning for 2026 revenue to be up in the range of 2% to 4% in total compared to 2025.

In the pre-market trading, The Timken Co is 2.94% lesser at $93.35 on the New York Stock Exchange.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19